Pharmatica
Discovery Loop
Discovery Loop explores AI-driven discovery, lead optimisation, biomarkers, translational science, lab automation, rare disease research, next-generation modalities and the decisions shaping how new therapies are identified and advanced.
Be sure to visit the podcast's website and support the creator: pharmatica.io
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Could Biological Ageing Be the Next Big Shift in Drug Discovery? 31.07.2026 25:33
In this special Scientific Council Spotlight episode of The Discovery Loop podcast , host Shubhangi Dua, Journalist, Podcast Producer and Podcast Host at Pharmatica.io , sits down with Deepankar Nayak, the CEO of Deep Longevity . Nayak also serves on Pharmatica’s Scientific Council . Together, the speakers on this pharma podcast unpack the true potential of biological ageing and why pharmaceutical...
Is AI Quietly Creating a GDPR Crisis in Clinical Research? 17.07.2026 28:38
Ask Diana Andrade what keeps global pharma compliance teams up at night, and she doesn't start with regulation. Instead, she addresses a misunderstanding. "The biggest gap and risk," she says, is the assumption that key-coded, pseudonymised patient data is not personal data at all. People think it’s therefore safe to use in AI tools without caution. That’s in fact a misconception. In an industry q...
Why Drug Discovery Breakthroughs Are Failing to Reach Patients 04.06.2026 29:50
Drug discovery has never moved faster. The tools available to researchers today, from AI-assisted molecular screening to advanced nanotechnology platforms, have dramatically compressed timelines that once took decades. Despite this acceleration, a troubling pattern persists, and that is most innovations developed in the laboratory never reach the patients who actually need them. In this episode of...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.